NEOPLASMS, NERVE TISSUE
Clinical trials for NEOPLASMS, NERVE TISSUE explained in plain language.
Never miss a new study
Get alerted when new NEOPLASMS, NERVE TISSUE trials appear
Sign up with your email to follow new studies for NEOPLASMS, NERVE TISSUE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sound waves boost brain cancer drug in new trial
Disease control Recruiting nowThis study tests whether adding a focused ultrasound device (NaviFUS) to the standard drug Avastin helps people with recurrent glioblastoma (a type of aggressive brain cancer) live longer without their cancer growing. About 32 adults whose cancer returned after standard treatment…
Matched conditions: NEOPLASMS, NERVE TISSUE
Phase: PHASE3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
Virus therapy takes on childhood brain cancer in early trial
Disease control Recruiting nowThis early-phase study tests whether a specially engineered virus called G207 is safe for children whose cerebellar brain tumors have come back or not responded to standard treatments. Up to 24 children aged 3 to 21 will receive the virus directly into the tumor, along with a low…
Matched conditions: NEOPLASMS, NERVE TISSUE
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Sound waves may help brain cancer drug reach tumors
Disease control Recruiting nowThis early-stage study tests whether combining a standard brain cancer drug (bevacizumab) with focused ultrasound can safely treat recurrent glioblastoma, an aggressive brain tumor. About 10 adults whose cancer has returned after standard therapy will receive the combination. The…
Matched conditions: NEOPLASMS, NERVE TISSUE
Phase: PHASE1, PHASE2 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 08, 2026 13:07 UTC